Travere Therapeutics
Pharmaceutical company
Based in CA
🤖
AI Overview
With $384K in lobbying spend across 20 quarterly filings, Travere Therapeutics is an active lobbying client. Their lobbying covers 6 issue areas. Active from 2021 to 2025.
$384K
Total Spend
5
Years Active
1
Firms Hired
1
Lobbyists Deployed
6
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2021 | $40K |
| 2022 | $105K |
| 2023 | $113K |
| 2024 | $62K |
| 2025 | $64K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Health Issues, Government Issues, Education, Medicare/Medicaid and 1 more
- •Educating congressional offices -- with a focus on minority caucus offices -- about rare kidney disease and a forthcoming legislative measure to address this issue.
- •Rare kidney disease
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
DOGE vs. the Lobbying Machine
Government efficiency meets the lobbying industrial complex.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.